ArticleJournal of global health2025
Epidemiology and risk factors for ovarian cancer incidence in the USA: a multilevel analysis.
Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: Ovarian cancer (OC) has the worst prognosis and highest death rate of all gynaecological cancers in the USA. We examined the independent effects of individual-, neighbourhood-, and state-level factors on ovarian cancer incidence using a multilevel analytical framework. Methods: In this retrospective cohort study, we analysed de-identified data from the All of Us research database, identifying women ≥18 years without prior ovarian cancer before January 2017. Participants were followed from 1 January 2017 through October 2023 (median follow-up: 6.6 years). Mixed-effects Cox regression models examined data on 85 388 individuals nested within ZIP-code areas and states, analysing individual-level risk factors and neighbourhood-level socioeconomic determinants, while accounting for geographic clustering. We fitted four progressive models: a null (random effects only), individual-level factors, neighbourhood-level factors, and full model with all covariates. Results: Among 85 388 women followed for a total of 569 847 person-years, 419 (0.49%) developed OC. Age demonstrated the strongest associations, with significantly elevated risks of developing OC among women aged 50-59 years (adjusted hazard ratio (aHR) = 1.83; 95% confidence interval (CI) = 1.28-2.61), 60-69 years (aHR = 2.01; 95% CI = 1.39-2.90), and ≥70 years (aHR = 1.67; 95% CI = 1.07-2.59) compared to those <40 years. Retired women had increased risk of OC compared to employed women (aHR = 1.39; 95% CI = 1.04-1.86). Non-Hispanic Black women demonstrated lower risk of OC than non-Hispanic White women (aHR = 0.63; 95% CI = 0.45-0.88). Regional variations showed 53% lower risk in the South vs. Northeast (aHR = 0.47; 95% CI = 0.25-0.86). Hormone replacement therapy was associated with increased risk of OC (aHR = 2.46; 95% CI = 1.07-5.67). Significant geographic clustering of OC was observed at neighbourhood and state levels. Conclusions: Individual-level factors, particularly age and employment status, are the primary determinants of OC risk, while apparent geographic disparities reflect population composition, rather than unmeasured environmental factors. The complete explanation of geographic clustering through measured covariates could provide important insights for targeted prevention strategies and future epidemiological research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.